Super thrilled to share our article on pharmacological PU.1 repositioning published in Nature Genetics today! Massive thanks to everyone involved!
Article -> https://t.co/h0rPMMq8qH
A digestible PUree of the main findings (aka Research Brief) -> https://t.co/1IoXUygs5p
1/23 We are excited to announce that our most recent study “In vivo dendritic cell reprogramming for cancer immunotherapy” was published in @ScienceMagazine.
https://t.co/yPDqKmpGnn
Here is a summary of what we discovered!
My favourite discovery ever has just come online. Can I please tell you about some seriously wacky molecular biology? The story starts with a reverse transcriptase that SOMEHOW defends bacteria from viruses.
(👇 I recommend sound ON for the video 🎹)
1/
🎉 Congratulations to @luisfholiveira, PhD student in the lab, for the #ISSCR2024 Exceptional Scientific Poster Presentation Award!
His poster “Transcription Factor Blueprints Underlying #Dendritic Cell Diversity” was selected amongst over 1400!
#Immunity#Reprogramming
🌟1/7 Check out our new pre-print “A cancer #immunotherapy modality based on dendritic cell #reprogramming in vivo”, where we reprogram #tumor cells in situ to efficiently present antigens as type 1 conventional dendritic cells (cDC1s). How effective is it?
✨ Catch the poster presentations by our lab members @halitzki, @nejcarh, @luisfholiveira and @nmalavika05 at #ISSCR2024!
📌 Check the flyer below for all information regarding times and poster numbers.
See you at the CCH – Congress Center Hamburg! ☺️
Impactful words by @CarolynBertozzi today on how diversity in her trainees enabled creativity, not playing by the rules, and ultimately the work that built the field of bioorthogonal chemistry. Diverse science leads to better science!
What a fantastic 3 days in Sälen!! in our lab retreat we had great group discussions and generated brilliant ideas for new research projects and how to better work together in the years to come @Lund_Stem @LuWcmm #labretreat
Check out our recent publication showing improved direct reprogramming of human fibroblasts to induced cDC1s mediated by the cooperation of PU.1, IRF8 and BATF3! @CellReproLab@Lund_Stem https://t.co/PXoFICAiX0
Really great day for @AsgardThx! We welcome @novoholdings, @Boehringer Ingelheim Venture Fund and @Industrifonden to our team! Looking forward to the next steps of developing in vivo Reprogramming approaches to fight cancer!
Please RT and spread the word!! @Idoyaga_Lab is recruiting again! NIH funded postdoc position to be filled immediately! If you love #DendriticCells#Macrophages#Monocytes, you cannot miss this exciting opportunity to work in a great collaborative and diverse environment!!
No better way to start the academic year than in a boat in Malmö full of reprogramming scientists! An exciting year ahead! @CellReproLab#Reprogramming#teambuilding
I am overjoyed to see two articles published back-to-back! Read in #ImmunityCP about our efforts to resolve monocyte and macrophage populations across human tissues and in #NatureAging about FMT's potential to mitigate age-related impairments!